R0-1 CA053615/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2008	1
2009	1
2010	1
2024	0

Page 1

Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350.

Young KA, Herbert AP, Barlow PN, Holers VM, Hannan JP. Young KA, et al. J Virol. 2008 Nov;82(22):11217-27. doi: 10.1128/JVI.01673-08. Epub 2008 Sep 10. J Virol. 2008. PMID: 18786993 Free PMC article.

Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.

Kovacs JM, Hannan JP, Eisenmesser EZ, Holers VM. Kovacs JM, et al. J Biol Chem. 2009 Apr 3;284(14):9513-20. doi: 10.1074/jbc.M808404200. Epub 2009 Jan 21. J Biol Chem. 2009. PMID: 19164292 Free PMC article.

Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair.

Kovacs JM, Hannan JP, Eisenmesser EZ, Holers VM. Kovacs JM, et al. J Biol Chem. 2010 Aug 27;285(35):27251-27258. doi: 10.1074/jbc.M110.106617. Epub 2010 Jun 17. J Biol Chem. 2010. PMID: 20558730 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year